Found: 48
Select item for more details and to access through your institution.
Effects of GLP-1 Receptor Agonists on Heart Rate and the Autonomic Nervous System Using Holter Electrocardiography and Power Spectrum Analysis of Heart Rate Variability.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet–Fed Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 15309, doi. 10.3390/ijms232315309
- By:
- Publication type:
- Article
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 20, p. 5237, doi. 10.3390/ijms20205237
- By:
- Publication type:
- Article
Acute Exacerbation of Anemia with Parvovirus B19 Infection One Year after Sleeve Gastrectomy for Severe Obesity.
- Published in:
- Internal Medicine, 2022, v. 61, n. 17, p. 2631, doi. 10.2169/internalmedicine.8446-21
- By:
- Publication type:
- Article
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of insulin degludec (IDeg)/insulin Aspart (IAsp) co‐formulation therapy twice‐daily with free combination of GLP‐1 receptor agonist liraglutide plus insulin degludec in Tochigi: IDEAL Trial.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 4, p. 1, doi. 10.1111/ijcp.13734
- By:
- Publication type:
- Article
Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 285, doi. 10.1111/dom.13520
- By:
- Publication type:
- Article
CD‐1<sup>db/db</sup> mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 6, p. 1470, doi. 10.1111/jdi.13311
- By:
- Publication type:
- Article
Macrophage‐specific hypoxia‐inducible factor‐1α deletion suppresses the development of liver tumors in high‐fat diet‐fed obese and diabetic mice.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 6, p. 1411, doi. 10.1111/jdi.13047
- By:
- Publication type:
- Article
Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 7, p. 2712, doi. 10.1210/jc.2006-1249
- By:
- Publication type:
- Article
Aldosterone Blockade Attenuates Urinary Monocyte Chemoattractant Protein-1 and Oxidative Stress in Patients with Type 2 Diabetes Complicated by Diabetic Nephropathy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 6, p. 2214, doi. 10.1210/jc.2005-1718
- By:
- Publication type:
- Article
Elevated Pregnancy-Associated Plasma Protein-A in Sera from Type 2 Diabetic Patients with Hypercholesterolemia: Associations with Carotid Atherosclerosis and Toe-Brachial Index.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 11, p. 5713, doi. 10.1210/jc.2004-0787
- By:
- Publication type:
- Article
Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4333, doi. 10.3390/jcm11154333
- By:
- Publication type:
- Article
Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0396-3
- By:
- Publication type:
- Article
Synergistic Association of Metabolic Syndrome and Overt Nephropathy With Elevated Asymmetric Dimethylarginine in Serum and Impaired Cutaneous Microvasodilation in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 4, p. 928, doi. 10.2337/diacare.29.04.06.dc05-2534
- By:
- Publication type:
- Article
Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Metabolic Syndrome Accompanied by Hypercholesterolemia Is Strongly Associated With Proinflammatory State and Impairment of Fibrinolysis in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2005, v. 28, n. 9, p. 2211, doi. 10.2337/diacare.28.9.2211
- By:
- Publication type:
- Article
Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Results of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Power spectral analysis of heart rate variation in diabetic patients with neuropathic foot ulceration.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Evaluation of skin vasomotor reflexes in response to deep inspiration in diabetic patients by laser Doppler flowmetry. A new approach to the diagnosis of diabetic peripheral autonomic neuropathy.
- Published in:
- 1997
- By:
- Publication type:
- journal article
A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 2619, doi. 10.1002/ccr3.3186
- By:
- Publication type:
- Article
Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 10, p. 2007, doi. 10.1002/ccr3.3047
- By:
- Publication type:
- Article
Application of differential display to identify genes for lung cancer detection in peripheral blood.
- Published in:
- International Journal of Cancer, 2002, v. 100, n. 5, p. 592, doi. 10.1002/ijc.10534
- By:
- Publication type:
- Article
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship Between Circulating Retinol Binding Protein-4 Levels and Various Markers Related to Insulin Resistance or Diabetic Complications in Hospitalized Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A588
- By:
- Publication type:
- Article
Effects of Pioglitazone or Voglibose on Circulating Total and High-Molecular-Weight Adiponectin, and on Two Fibrinolysis Inhibitors, in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A87
- By:
- Publication type:
- Article
PPARð Agonists Suppress Osteopontin Expression in Macrophages and Decrease Plasma Levels in Patients With Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, n. 6, p. 1662, doi. 10.2337/db06-1177
- By:
- Publication type:
- Article
Comparison of Serum High-Molecular Weight (HMW) Adiponectin With Total Adiponectin Concentrations in Type 2 Diabetic Patients With Coronary Artery Disease Using a Novel Enzyme-Linked Immunosorbent Assay to Detect HMW Adiponectin.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34CXCR4 cells in patients with type 2 diabetes.
- Published in:
- Endocrine (1355008X), 2015, v. 50, n. 3, p. 659, doi. 10.1007/s12020-015-0688-5
- By:
- Publication type:
- Article
Erratum to: Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM).
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM).
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 4, p. 821, doi. 10.1007/s13300-017-0274-3
- By:
- Publication type:
- Article
Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Study.
- Published in:
- 2017
- By:
- Publication type:
- Report
A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50/50 vs. Aspart-70/30 in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2014, v. 5, n. 2, p. 403, doi. 10.1007/s13300-014-0078-7
- By:
- Publication type:
- Article
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes.
- Published in:
- Diabetology & Metabolic Syndrome, 2016, v. 8, p. 1, doi. 10.1186/s13098-016-0169-x
- By:
- Publication type:
- Article
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
- Published in:
- Endocrine Journal, 2022, v. 69, n. 8, p. 941, doi. 10.1507/endocrj.ej21-0656
- By:
- Publication type:
- Article
Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
- Published in:
- Endocrine Journal, 2021, v. 68, n. 10, p. 1187, doi. 10.1507/endocrj.ej20-0717
- By:
- Publication type:
- Article
Concurrent variant type 3 autoimmune polyglandular syndrome and pulmonary arterial hypertension in a Japanese woman.
- Published in:
- Endocrine Journal, 2018, v. 65, n. 4, p. 493, doi. 10.1507/endocrj.ej17-0465
- By:
- Publication type:
- Article
Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: The GREAT clinical study.
- Published in:
- Endocrine Journal, 2018, v. 65, n. 1, p. 101, doi. 10.1507/endocrj.ej17-0330
- By:
- Publication type:
- Article
Improvement of Glycemic Control by Re-education in Insulin Injection Technique in Patients with Diabetes Mellitus.
- Published in:
- Advances in Therapy, 2013, v. 30, n. 10, p. 897, doi. 10.1007/s12325-013-0066-8
- By:
- Publication type:
- Article
Effects of treatment with methimazole on circulating CD4<sup>+</sup> and CD8<sup>+</sup> T cells positive for programed cell death protein‐1 and on subsets of CD4<sup>+</sup> T cells in untreated hyperthyroid patients with Graves' disease.
- Published in:
- Clinical Endocrinology, 2022, v. 97, n. 6, p. 841, doi. 10.1111/cen.14788
- By:
- Publication type:
- Article
1150-P: Empagliflozin Decreases the Plasma Concentration of Plasminogen Activator Inhibitor-1 (PAI-1) in Patients with Type 2 Diabetes: Association with Improvement of Fibrinolysis.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1150-P
- By:
- Publication type:
- Article
2186-PUB: Comparison of Insulin Degludec (IDeg)/Insulin Aspart (IAsp) Coformulation Therapy Twice Daily with Free Combination of GLP-1 Receptor Agonist Liraglutide plus Insulin Degludec in Tochigi: IDEAL Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2186-PUB
- By:
- Publication type:
- Article
1106-P: Effects of Long-Term Dapagliflozin Treatment on Hemorheology (D-PATH Study).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1106-P
- By:
- Publication type:
- Article
132-OR: Effects of Dapagliflozin, an SGLT2 Inhibitor, on Hepatic Steatosis and Fibrosis Evaluated by Transient Elastography in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-132-OR
- By:
- Publication type:
- Article
1229-P: Dapagliflozin Improves Liver Dysfunction in Parallel with a Decrease in Serum Soluble DPP-4/CD26 Level in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1229-P
- By:
- Publication type:
- Article